1. Home
  2. FAX vs XERS Comparison

FAX vs XERS Comparison

Compare FAX & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FAX
  • XERS
  • Stock Information
  • Founded
  • FAX 1986
  • XERS 2005
  • Country
  • FAX United States
  • XERS United States
  • Employees
  • FAX N/A
  • XERS N/A
  • Industry
  • FAX Investment Managers
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FAX Finance
  • XERS Health Care
  • Exchange
  • FAX Nasdaq
  • XERS Nasdaq
  • Market Cap
  • FAX 619.2M
  • XERS 628.7M
  • IPO Year
  • FAX N/A
  • XERS 2018
  • Fundamental
  • Price
  • FAX $15.36
  • XERS $5.16
  • Analyst Decision
  • FAX
  • XERS Strong Buy
  • Analyst Count
  • FAX 0
  • XERS 5
  • Target Price
  • FAX N/A
  • XERS $6.10
  • AVG Volume (30 Days)
  • FAX 833.6K
  • XERS 2.3M
  • Earning Date
  • FAX 01-01-0001
  • XERS 05-08-2025
  • Dividend Yield
  • FAX 12.09%
  • XERS N/A
  • EPS Growth
  • FAX N/A
  • XERS N/A
  • EPS
  • FAX N/A
  • XERS N/A
  • Revenue
  • FAX N/A
  • XERS $222,551,000.00
  • Revenue This Year
  • FAX N/A
  • XERS $31.75
  • Revenue Next Year
  • FAX N/A
  • XERS $21.09
  • P/E Ratio
  • FAX N/A
  • XERS N/A
  • Revenue Growth
  • FAX N/A
  • XERS 29.88
  • 52 Week Low
  • FAX $2.33
  • XERS $1.72
  • 52 Week High
  • FAX $2.84
  • XERS $6.07
  • Technical
  • Relative Strength Index (RSI)
  • FAX 55.12
  • XERS 63.30
  • Support Level
  • FAX $14.37
  • XERS $4.26
  • Resistance Level
  • FAX $15.43
  • XERS $4.77
  • Average True Range (ATR)
  • FAX 0.20
  • XERS 0.28
  • MACD
  • FAX 0.05
  • XERS 0.08
  • Stochastic Oscillator
  • FAX 78.21
  • XERS 91.32

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities and others.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: